These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 9725232

  • 1. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
    Fletcher JM, Prentice HG, Grundy JE.
    J Immunol; 1998 Sep 01; 161(5):2365-74. PubMed ID: 9725232
    [Abstract] [Full Text] [Related]

  • 2. Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors.
    Lang P, Griesinger A, Hamprecht K, Feuchtinger T, Schumm M, Neuhäuser F, Greil J, Martin D, Handgretinger R, Niethammer D.
    Hum Immunol; 2004 May 01; 65(5):423-31. PubMed ID: 15172441
    [Abstract] [Full Text] [Related]

  • 3. Human natural killer cell lysis of virus-infected cells. Relationship to expression of the transferrin receptor.
    Borysiewicz LK, Graham S, Sissons JG.
    Eur J Immunol; 1986 Apr 01; 16(4):405-11. PubMed ID: 3009202
    [Abstract] [Full Text] [Related]

  • 4. A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells.
    Huard B, Früh K.
    Eur J Immunol; 2000 Feb 01; 30(2):509-15. PubMed ID: 10671206
    [Abstract] [Full Text] [Related]

  • 5. Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts.
    Cerboni C, Mousavi-Jazi M, Linde A, Söderström K, Brytting M, Wahren B, Kärre K, Carbone E.
    J Immunol; 2000 May 01; 164(9):4775-82. PubMed ID: 10779784
    [Abstract] [Full Text] [Related]

  • 6. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF, Welsh RM.
    J Immunol; 1985 Nov 01; 135(5):3537-41. PubMed ID: 2413125
    [Abstract] [Full Text] [Related]

  • 7. IFN increases class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing.
    Routes JM.
    J Immunol; 1992 Oct 01; 149(7):2372-7. PubMed ID: 1382100
    [Abstract] [Full Text] [Related]

  • 8. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
    Borysiewicz LK, Rodgers B, Morris S, Graham S, Sissons JG.
    J Immunol; 1985 Apr 01; 134(4):2695-701. PubMed ID: 2579152
    [Abstract] [Full Text] [Related]

  • 9. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
    Pietra G, Semino C, Cagnoni F, Boni L, Cangemi G, Frumento G, Melioli G.
    J Med Virol; 2000 Nov 01; 62(3):354-63. PubMed ID: 11055246
    [Abstract] [Full Text] [Related]

  • 10. [Immune reaction to human cytomegalovirus].
    Ito M.
    Nihon Rinsho; 1998 Jan 01; 56(1):62-8. PubMed ID: 9465666
    [Abstract] [Full Text] [Related]

  • 11. NK recognition of cytomegalovirus-infected endothelial cells depends on viral replication and MHC class I expression.
    Weinberg A, Zhang L, Tuder RM.
    Viral Immunol; 1996 Jan 01; 9(2):131-40. PubMed ID: 8822629
    [Abstract] [Full Text] [Related]

  • 12. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
    Kaufman DS, Schoon RA, Leibson PJ.
    J Immunol; 1993 Feb 15; 150(4):1429-36. PubMed ID: 8432986
    [Abstract] [Full Text] [Related]

  • 13. Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells.
    Pietra G, Romagnani C, Mazzarino P, Millo E, Moretta L, Mingari MC.
    Eur J Immunol; 2003 Dec 15; 33(12):3427-32. PubMed ID: 14635052
    [Abstract] [Full Text] [Related]

  • 14. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV, Welsh RM, Haspel MV.
    J Immunol; 1986 Feb 15; 136(4):1446-53. PubMed ID: 3003198
    [Abstract] [Full Text] [Related]

  • 15. CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity.
    Chong AS, Boussy IA, Jiang XL, Lamas M, Graf LH.
    Cell Immunol; 1994 Aug 15; 157(1):92-105. PubMed ID: 7518755
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM, Karpinski BA, Gottschalk L, Kornbluth J.
    J Immunol; 1989 Mar 15; 142(6):2140-7. PubMed ID: 2493507
    [Abstract] [Full Text] [Related]

  • 17. Characteristics of human T-lymphotropic virus type-1 (HTLV-1)-infected cell line MT-2, which is not killed by a natural killer cell line NK-92 but is killed by lymphokine-activated killer cells.
    Komatsu F, Yoshida S.
    Oncol Res; 1999 Mar 15; 11(5):213-8. PubMed ID: 10608615
    [Abstract] [Full Text] [Related]

  • 18. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T, Jarousseau AC, Watier H, Boucraut J, Le Bouteiller P, Bardos P, Thibault G.
    J Immunol; 1999 May 15; 162(10):5902-9. PubMed ID: 10229826
    [Abstract] [Full Text] [Related]

  • 19. UL40-mediated NK evasion during productive infection with human cytomegalovirus.
    Wang EC, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK, Braud VM, Wilkinson GW.
    Proc Natl Acad Sci U S A; 2002 May 28; 99(11):7570-5. PubMed ID: 12032324
    [Abstract] [Full Text] [Related]

  • 20. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F, Kajiwara M.
    Oncol Res; 1998 May 28; 10(10):483-9. PubMed ID: 10338151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.